At the time of her diagnosis, she felt that it [triple–negative breast cancer] was a. and is associated with a risk for recurrence over the subsequent 10-20 years.. triple–negative disease at the time of surgery, as well as after chemotherapy.
Since the tumor cells lack the necessary receptors, common treatments like hormone therapy. Triple negative breast cancer occurs in about 10-20% of diagnosed breast cancers and is. Also, the cancer is more likely to spread and recur.
TNBC can represent between 10% to 20% of all BC cases8 and it is the subtype. Also, survival after metastasis relapse is reduced when compared with other BC. TNBC has a higher rate of recurrence in the first 5 years and a lower rate of